Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching InsteadApril 21, 2026
The Key Biomarkers Changing How and When We Diagnose Alzheimer’s DiseaseNews DeskApril 16, 20260 Alzheimer’s disease continues to be one of the most daunting public health challenges of our time. In the United States…